Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 2 papers. Top paper: “Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics—CheckMate 908”.
François Doz, Nicholas K. Foreman, Darren Hargrave, Álvaro Lassaletta, Nicolás André +14 more
Mayra Shanley, Rafet Başar, May Daher, Joy Gumin, Daniel B. Zamler +45 more